Date: Monday 30th September - Thursday 3rd October 2024
Location: Edinburgh International Conference Centre (EICC)
The MRC-NIHR Trials Methodology Research Partnership is delighted to welcome you to the 7th International Clinical Trials Methodology Conference 2024.
ICTMC is the leading international platform for researchers and practitioners to present the very latest in trials methodology. The meeting also offers valuable networking and training opportunities, with 900 delegates from 16 countries attending in 2022.
The 2024 conference will take place in the capital city of Scotland, Edinburgh, which is known worldwide for the amazing events taking place throughout the year. The city boasts an abundance of historic sites and magnificent architecture in the city centre. We hope you take this opportunity to extend your visit to explore the Old and New Town, discover vibrant dining spots and immerse yourself in the city’s atmosphere.
The meeting venue is the Edinburgh International Conference Centre (EICC), an impressive purpose-built conference centre that offers the very best facilities and technology. A variety of accommodation options are available within short walking distance to suit any budget. We also hope many of you will join us for the Conference Party which promises to be a fun and unforgettable event.
A diverse programme will be prepared by the Scientific Committee and Education Committee, which promises to make this a highly rewarding and enjoyable meeting for all.
To find out more about this event, please click here.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
